Please assess the completion status of the following clinical trial:

Trial Title: Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with histopathological diagnosis of mammary cancer who are candidate for tumorectomy, either with SLN selective lymphadenectomy, or with complete axillary node dissection,~* Informed consent form signed.~Exclusion Criteria:~* Diagnosis of mammary cancer established by gross biopsy,~* Age less than18 years old.~* Inability to give informed consent.~* History of allergy or hypersensitivity against the investigational product (its active substance or ingredients), to iodine or to shellfish.~* Apparent hyperthyroidism, autonomous thyroid adenoma, unifocal, multifocal or disseminated autonomies of the thyroid gland.~* Documented coronary disease.~* Advanced renal impairment (creatinine \> 1,5mg/dl).~* During the 2 weeks before the enrolment, concurrent medication which reduces or increases the extinction of ICG (i.e. anticonvulsants, haloperidol and Heparin).~* Pregnancy, breastfeeding

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Indocyanine Green (Type: EXPERIMENTAL): study of the correlation between fluorescence and margins of the tumours after iv injection of Indocyanine Green

Based on this trial design, predict the completion outcome and termination type (if applicable).